Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) FCF Margin (2017 - 2026)

Inspire Medical Systems' FCF Margin history spans 10 years, with the latest figure at 1.53% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 648.0% to 1.53% in Q1 2026 year-over-year; TTM through Mar 2026 was 13.69%, a 18.0% increase, with the full-year FY2025 number at 12.3%, down 350.0% from a year prior.
  • FCF Margin hit 1.53% in Q1 2026 for Inspire Medical Systems, down from 19.68% in the prior quarter.
  • Over the last five years, FCF Margin for INSP hit a ceiling of 30.76% in Q3 2025 and a floor of 20.12% in Q1 2022.
  • Historically, FCF Margin has averaged 5.85% across 5 years, with a median of 1.53% in 2026.
  • Biggest five-year swings in FCF Margin: tumbled -1213bps in 2023 and later soared 2812bps in 2024.
  • Tracing INSP's FCF Margin over 5 years: stood at 16.93% in 2022, then crashed by -72bps to 4.8% in 2023, then soared by 502bps to 28.89% in 2024, then plummeted by -32bps to 19.68% in 2025, then plummeted by -92bps to 1.53% in 2026.
  • Business Quant data shows FCF Margin for INSP at 1.53% in Q1 2026, 19.68% in Q4 2025, and 30.76% in Q3 2025.